Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondriaSaroj P. Mathupala, Peter L. Pedersen, Young Hee Ko|Oncogene|2006Cited by 756
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapySaroj P. Mathupala, Peter L. Pedersen, Young Hee Ko|Seminars in Cancer Biology|2008Cited by 585
Glucose Catabolism in Cancer CellsSaroj P. Mathupala, Peter L. Pedersen, Annette Rempel|Journal of Biological Chemistry|2001Cited by 362
Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionPeter L. Pedersen, Young Hee Ko, Saroj P. Mathupala et al.|Biochimica et Biophysica Acta (BBA) - Bioenergetics|2002Cited by 350
Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II HexokinaseSaroj P. Mathupala, Peter L. Pedersen, Annette Rempel|Journal of Bioenergetics and Biomembranes|1997Cited by 247